Baker Bros. Advisors »

Aligos Therapeutics shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Aligos Therapeutics shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $719k 83k 8.66

More positions owned by Baker Bros. Advisors

BeiGene Sponsored Adr (BGNE)
Incyte Corporation (INCY)
ACADIA Pharmaceuticals (ACAD)
Summit Therapeutics (SMMT)
Madrigal Pharmaceuticals (MDGL)
Revolution Medicines (RVMD)
Rhythm Pharmaceuticals (RYTM)
Insmed Incorporated Com Par $.01 (INSM)
Kymera Therapeutics (KYMR)
Bicycle Therapeutics Sponsored Ads (BCYC)
Edgewise Therapeutics (EWTX)
Replimune Group (REPL)
Alkermes SHS (ALKS)
Denali Therapeutics (DNLI)
Insmed Incorporated Note 0.75% 6/1/2028 (Principal)

View all positions for Baker Bros. Advisors

Top funds holding Aligos Therapeutics

Woodline Partners
Baker Bros. Advisors
Hillhouse Capital Advisors
Acadian Asset Management
Geode Capital Management
Renaissance Technologies
Charles Schwab Investment Management
BlackRock
Bank of America Corporation
CWM
Advisor Group Holdings
AlphaMark Advisors
Jpmorgan Chase & Co
Zrc Wealth Management
Bnp Paribas Arbitrage, Snc

View all funds holding Aligos Therapeutics